Asset Dedication LLC’s Charles River Laboratories CRL Stock Holding History

Asset Dedication LLC’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$681	Sell	3 -88	-97%	-$15.7K	﹤0.01%	1137
2026 Q1	$15.7K	Hold	91	–	–	﹤0.01%	679
2025 Q4	$18.2K	Hold	91	–	–	﹤0.01%	678
2025 Q3	$14.2K	Sell	91 -13	-13%	-$2.06K	﹤0.01%	738
2025 Q2	$15.8K	Buy	104 +13	+14%	+$1.73K	﹤0.01%	742
2025 Q1	$13.7K	Hold	91	–	–	﹤0.01%	717
2024 Q4	$16.8K	Hold	91	–	–	﹤0.01%	687
2024 Q3	$17.9K	Hold	91	–	–	﹤0.01%	710
2024 Q2	$18.8K	Hold	91	–	–	﹤0.01%	693
2024 Q1	$25K	Hold	91	–	–	﹤0.01%	543
2023 Q4	$22K	Hold	91	–	–	﹤0.01%	553
2023 Q3	$18K	Buy	91 +3	+3%	+$616	﹤0.01%	585
2023 Q2	$19K	Hold	88	–	–	﹤0.01%	564
2023 Q1	$18K	Hold	88	–	–	﹤0.01%	570
2022 Q4	$19K	Buy	+88	New	+$19.2K	﹤0.01%	557
2021 Q4	–	Sell	-9	Closed	-$4K	–	945
2021 Q3	$4K	Buy	+9	New	+$3.74K	﹤0.01%	812

Other funds holding CRL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Asset Dedication LLC's CRL Position: Q2 2026 in Review

Asset Dedication LLC reduced its Charles River Laboratories (CRL) stake by 97% in Q2 2026, selling an estimated $15.7K and leaving 3 shares worth $681. The position accounts for ﹤0.01% of the portfolio, ranked #1137.

Asset Dedication LLC first reported a position in CRL in Q3 2021 and has held it in 16 quarters since. The position peaked at $25K in Q1 2024. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

Asset Dedication LLC held 3 shares of Charles River Laboratories worth $681 as of Q2 2026.
Asset Dedication LLC sold 88 Charles River Laboratories shares in Q2 2026, an estimated $15.7K.
Charles River Laboratories made up ﹤0.01% of Asset Dedication LLC's portfolio in Q2 2026, its #1137 holding.
Asset Dedication LLC first reported a position in Charles River Laboratories in Q3 2021 and has held it in 16 quarters since.
Asset Dedication LLC's Charles River Laboratories position peaked at $25K in Q1 2024.
563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Asset Dedication LLC's 13F filing for Q2 2026, filed 30 Jul 2026.